Key result
An mRNA booster vaccination in adults older than 65 years increased SARS-CoV-2 neutralizing antibodies to near 100% positivity against European, Delta, and Omicron variants by day 15.
Why the study?
Does mRNA COVID-19 vaccine booster improve SARS-CoV-2 neutralizing antibodies against delta and omicron variants in adults older than 65 years?
Observational (n=65)
Yes
Does mRNA COVID-19 vaccine booster improve SARS-CoV-2 neutralizing antibodies against delta and omicron variants in adults older than 65 years?
A first mRNA booster dose elicits a neutralizing antibody response against delta and omicron variants in older adults starting 5 days post-vaccination.
Answers are grounded in this paper and cite their sources.
May inform booster timing in older adults; leaves open clinical protection against variants.
Immune response induced by COVID-19 vaccine booster against delta and omicron variants was assessed in 65 adults (65-84 years old) early aftesr a first booster dose. An increase in SARS-CoV-2 neutralizing antibodies was shown in individuals not previously infected without evidence of an age-related effect, with lower increase in those infected before a single dose of primary vaccination. Of note, humoral response was observed only starting from the 5th day after the boost.
No takes yet. Share an insight, caveat, or question.
Durier et al. (2022) conducted an observational in COVID-19 (n=65). mRNA COVID-19 booster vaccination vs. Pre-booster baseline was evaluated on Neutralizing antibody positivity against SARS-CoV-2 variants at day 15 post-boost. An mRNA booster vaccination in adults older than 65 years increased SARS-CoV-2 neutralizing antibodies to near 100% positivity against European, Delta, and Omicron variants by day 15.
Synapse has enriched 10 related papers. Consider them for comparative context: